2nd Quarter - Report

C2 GROUP, LLC for AMGEN USA INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 19, 2010 $50,000 Replaced
2nd Quarter - Report Jul 20, 2010 $50,000 Replaced
2nd Quarter - Amendment Jul 20, 2010 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare and Medicaid Reimbursement Issue; S. 1796, America's Healthy Future Act (Medicaid Drug Rebate Program), H.R. 3590, The Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Reconciliation Act of 2010.

LobbyistCovered position, as disclosed
G HUNTER BATES —
LESLEY ELLIOTT —
JEFFERIES MURRAY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1796 (111th), H.R. 4872 (111th), H.R. 3590 (111th)

Health Issues HCR

Biosimilars H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548, Pathway for Biosimilar Act H.R. 3962, Affordable Health Care for America Act; H.R. 3590, The Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Reconciliation Act of 2010.

LobbyistCovered position, as disclosed
G HUNTER BATES —
LESLEY ELLIOTT —
JEFFERIES MURRAY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), S. 726 (111th), H.R. 4872 (111th), H.R. 1427 (111th), H.R. 3590 (111th), H.R. 3962 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.